Some argue that allowing peptides to be compounded will ensure a safer peptide supply
Back home, scrolling online, you may come across a buzzy new GLP-1 that costs $100 for a month's supply, and supposedly preserves muscle while melting fat
There are no clear estimates of how big this market is, but the information experts do have suggests it is sizable
The companies listed in this report are a curated selection - not the full competitive universe
Commonly reported side effects include: Nausea, vomiting, and diarrhoea particularly during dose escalation Constipation and abdominal discomfort Decreased appetite and early satiety Injection site reactions (mild and transient) Fatigue, especially in the initial weeks of treatment These gastrointestinal effects are consistent with the GLP-1 mechanism and are generally dose-dependent and transient
Survodutide vs Retatrutide: Dual vs Triple Agonist Survodutide and retatrutide are both investigational obesity drugs that add glucagon to GLP-1, but retatrutide goes a step further by also targeting GIP